Global Genomics In Cancer Care Market Worth USD 9.22 Billion by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Illumina, Agilent Technologies, Roche Diagnostics - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Genomics In Cancer Care Market Analysis By Product, By Application, By Technology, By End-use And Segment Forecasts To 2022" report to their offering.

Global genomics in cancer care market is expected to reach USD 9.22 billion by 2022. Increasing prevalence of cancer coupled with adoption of next generation sequencing for the diagnosis & treatment is expected to fuel the market with future growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and accurate diagnostics in coming years.

In addition, increasing demand for personalized medicines in molecular characterization of cancer to identify therapeutic targets is the factor attributing towards the market growth. Similarly, factors such as cost reduction in genome sequencing, growing healthcare expenditure levels and development of effective diagnostics & therapeutic procedures for cancer are responsible for the potential growth of genomics in cancer care.

Instrument segment dominated the overall market in terms of revenue share as of 2014 and accounted for 33.4% of market owing to high cost associated with it. Whereas, consumables are most widely used product segment in genome testing as they are indispensible component and frequently required to perform the test.

Companies Mentioned:

  • Illumina Inc
  • Agilent Technologies
  • Roche Diagnostics
  • Cancer Genetics Inc
  • Bio-Rad Laboratories
  • Sigma Aldrich
  • Qiagen
  • Perkin Elmer
  • Affymetrix
  • BGI
  • Life technologies
  • GE Healthcare
  • Pacific Biosciences
  • Strategic Initiatives
  • Myriad Genetics
  • Luminex
  • Abbott Molecular
  • Beckman Coulter, Inc
  • Oxford Gene Technology Ltd.

Report Structure:

1. Methodology and Scope

2. Executive Summary

3. Genomics In Cancer Care Industry Outlook

4. Genomics In Cancer Care Product Outlook

5. Genomics In Cancer Care Application Outlook

6. Genomics In Cancer Care Technology Outlook

7. Genomics In Cancer Care End-use Outlook

8. Genomics In Cancer Care Regional Outlook

9. Competitive Landscape

For more information visit http://www.researchandmarkets.com/research/fd4d78/genomics_in

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Genomics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Genomics